Mestinon (pyridostigmine) works by blocking the enzyme that breaks down acetylcholine, a chemical messenger your nerves use to signal your muscles. By slowing that breakdown, more acetylcholine stays available at the junction between nerve and muscle, which strengthens muscle contractions. The effect begins within about 30 minutes of taking a tablet and, with repeated dosing, can last up to seven or eight hours.
The Core Mechanism: Keeping Acetylcholine Around Longer
Every time a nerve tells a muscle to contract, it releases acetylcholine into the tiny gap (called the synaptic cleft) between the nerve ending and the muscle fiber. Acetylcholine latches onto receptors on the muscle, triggering a contraction. Almost immediately, an enzyme called acetylcholinesterase chops that acetylcholine apart so the signal doesn’t keep firing indefinitely.
Mestinon temporarily blocks acetylcholinesterase. With the enzyme out of commission, acetylcholine molecules linger in the gap longer and activate more receptors before they’re eventually cleared. The result is a stronger, more reliable signal from nerve to muscle. Importantly, pyridostigmine’s chemical structure prevents it from crossing into the brain, so its effects stay confined to the body’s peripheral nerves and muscles.
How It Helps in Myasthenia Gravis
Myasthenia gravis is an autoimmune condition in which your immune system attacks the acetylcholine receptors on your muscles. With fewer working receptors, normal amounts of acetylcholine aren’t enough to produce a full muscle contraction. That’s why people with myasthenia gravis experience drooping eyelids, double vision, difficulty swallowing, and limb weakness that worsens with activity.
By boosting the amount of acetylcholine available, Mestinon compensates for the missing receptors. A 2024 randomized, placebo-controlled trial published in Neurology confirmed this effect with hard numbers: patients on pyridostigmine scored an average of 5.3 points better on a standardized disease severity scale compared to placebo. The improvement showed up across every category measured, including eye muscles, general body strength, daily functioning, and quality of life. It’s the first-line symptomatic treatment for the condition, meaning it manages the symptoms rather than targeting the underlying immune attack.
Why It’s Used for POTS
Mestinon is also prescribed off-label for postural orthostatic tachycardia syndrome (POTS), a condition where your heart rate spikes excessively when you stand up. The mechanism here is different from its role in myasthenia gravis.
Acetylcholine isn’t just a muscle messenger. It’s also the chemical your parasympathetic nervous system (the “rest and digest” branch) uses to slow heart rate. When Mestinon blocks the enzyme that degrades acetylcholine, more of it accumulates at the nerve endings that feed the heart. This boosts parasympathetic signaling, which puts the brakes on heart rate. Research from the American Heart Association found that the primary benefit in POTS patients is this reduction in heart rate through enhanced parasympathetic tone, rather than any direct effect on blood pressure or blood volume.
How Quickly It Works and How Long It Lasts
The standard immediate-release tablet starts working within 15 to 30 minutes. Blood levels peak at roughly 1.5 hours on an empty stomach, or around 2 hours if you’ve eaten. A single dose produces meaningful enzyme inhibition (in the range of 20 to 40 percent) for about four to five hours.
With repeated dosing throughout the day, the effect builds. Multiple doses push enzyme inhibition up to 41 to 49 percent, and the therapeutic window stretches to seven or eight hours per dose. That’s why most people take Mestinon several times a day rather than once.
An extended-release version is also available. It reaches peak blood levels more slowly (about 2.5 hours fasting, potentially longer with food) and maintains its enzyme-blocking effect for roughly nine hours per dose. This formulation is often taken at bedtime so muscle strength holds through the night and into the morning.
Common Side Effects
Because Mestinon increases acetylcholine everywhere outside the brain, not just at the muscles you want to strengthen, it can overstimulate other tissues that respond to acetylcholine. The gut is especially sensitive. In FDA clinical trial data, diarrhea and abdominal pain were the most common side effects, each occurring in about 7 percent of patients compared to 0 percent on placebo. Muscle twitching is also reported.
These side effects are dose-related. Most people find that starting at a lower dose and gradually increasing helps the body adjust. Eating with the medication can also soften the gastrointestinal effects.
Cholinergic Crisis: Too Much of a Good Thing
If the dose is far too high, acetylcholine can accumulate to the point where it actually blocks muscle function instead of enhancing it. This is called a cholinergic crisis, and it’s a medical emergency. The muscles become paradoxically weaker because the receptors are overwhelmed by constant stimulation and stop responding.
The warning signs are distinct from a worsening of the underlying disease. A cholinergic crisis typically comes with excessive salivation, profuse sweating, nausea, vomiting, blurred vision, and cramping on top of muscle weakness. A myasthenic crisis (worsening of myasthenia gravis itself) causes weakness without those extra cholinergic symptoms. The distinction matters because the treatments are opposite: a myasthenic crisis needs more medication, while a cholinergic crisis needs less.
Who Should Not Take It
Mestinon is contraindicated for anyone with a mechanical obstruction in the intestines or urinary tract. Because the drug increases activity in smooth muscle (the type lining your gut and bladder), it could worsen a blockage. It’s also not appropriate for anyone with a known allergy to pyridostigmine or related compounds.
The drug is cleared primarily through the kidneys, excreted partly as the unchanged drug and partly as breakdown products. In people with severely impaired kidney function, the drug’s half-life triples and clearance drops by about 75 percent, meaning it stays in the body much longer and the risk of side effects increases significantly.